This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Idexx Laboratories (IDXX)

NASDAQ: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.38B 1.29B 1.22B 1.10B
Cost of Sales 566.34M 541.78M 523.98M 478.81M
Gross Operating Profit 810.71M 751.56M 694.71M 624.58M
Selling, General, and Administrative Expenses 401.35M 354.57M 334.24M 306.14M
Research & Development 88.00M 82.01M 76.04M 68.60M
Operating Income before D & A (EBITDA) 321.36M 314.97M 284.43M 249.84M
Depreciation & Amortization 54.60M 52.41M 48.20M 45.96M
Interest Income 1.88M 1.90M 1.74M 663.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 268.65M 264.46M 237.97M 204.54M
Interest Expense 5.39M 3.85M 3.55M 2.42M
Pre-Tax Income 263.26M 260.62M 234.42M 202.13M
Income Taxes 75.47M 82.33M 72.67M 60.81M
Minority Interest -6.00K 20.00K -32.00K 36.00K
Net Income From Continuing Operations 187.79M 178.29M 161.75M 141.32M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 187.79M 178.29M 161.75M 141.32M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 187.80M 178.27M 161.79M 141.28M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
187.79M 178.29M 161.75M 141.32M
Preferred Dividends
Net Income Available To Common 187.79M 178.29M 161.75M 141.32M
Basic EPS from Continuing Ops. 3.53 3.24 2.85 2.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.53 3.24 2.85 2.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.53 3.24 2.85 2.45
Basic Normalized Net Income/Share 3.53 3.24 2.85 2.45
EPS fr Continuing Ops. 3.48 3.17 2.78 2.37
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.48 3.17 2.78 2.37
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.48 3.17 2.78 2.37
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.48 3.17 2.78 2.37
Dividends Paid per Share 0.00 0.00 0.00 0.00
IDXX News

IDXX Idexx Laboratories

Analysts Ratings for IDXX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 4 4
Moderate Buy 1 1 1 1
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
GET IDXX ANALYST REPORT

Brokerage Partners

IDXX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs